The Shifting Paradigm Towards Oral Factor Xa Anticoagulation for Stroke Prevention in Vulnerable Patients with AF: Rationale, Safety Issues, and Evidence in Support of NOAC Therapy

The Shifting Paradigm Towards Oral Factor Xa Anticoagulation for Stroke Prevention in Vulnerable Patients with AF: Rationale, Safety Issues, and Evidence in Support of NOAC Therapy


Published

January 29, 2018

Created by

CMEducation Resources symposium